TY - T1的唾液SARS-C分子检测oV-2: simplifying the diagnosis without losing accuracy JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.02099-2021 SP - 2102099 AU - Saluzzo, Francesca AU - Mantegani, Paola AU - Poletti de Chaurand, Valeria AU - Cugnata, Federica AU - Rovere-Querini, Patrizia AU - Cilla, Marta AU - Erba, Patrizia Paola AU - Racca, Sara AU - Tresoldi, Cristina AU - Uberti-Foppa, Caterina AU - Di Serio, Clelia AU - Cirillo, Daniela Maria Y1 - 2021/01/01 UR - //www.qdcxjkg.com/content/early/2021/09/29/13993003.02099-2021.abstract N2 - The possibility to rely on rapid and accurate diagnostic techniques has proved itself crucial during the last year to contain the spreading of SARS-CoV-2 infection [1]. Even if quantitative RT-PCR (RT-qPCR) on NasoPharyngeal Swabs (NPS) is still considered the standard for COVID19 diagnosis, saliva has been evaluated in several studies as a possible alternative to NPS and is currently extensively utilised in South Korea, Germany, and Japan [2, 3]. Nonetheless, the use of saliva is still debated, and a rigorous standardisation of the analysis protocol is greatly needed [4–6]. The application of point of care (POC) technologies on saliva, able to rapidly perform highly specific and sensitive molecular testing, could prove invaluable to allow the diagnosis also in challenging and remote settings by simplifying and speeding up the diagnostic process [1].Acknowledgements:We thank DiaSorin Italia and Cepheid Italia for providing the reagents to perform the study free of charge. ER -